The eIF3a mRNA and protein expression level in cancer tissues of these patients were firstly evaluated by realtime reverse transcriptase (RT)-PCR (Figure 1A) and immunohistochemistry (IHC) (Figure 1B and 1C), respectively. Here, EIF3A is linked to cancer.